A zebrafish-centric approach to antiepileptic drug development.
A zebrafish-centric approach to antiepileptic drug development.
复制标题
DOI:
10.1242/dmm.049080
复制
发表时间:
2021-07-01
影响因子:
4.3
通讯作者:
Baraban SC
中科院分区:
文献类型:
--
作者:
Baraban SC
Danio rerio (zebrafish) are a powerful experimental model for genetic and developmental studies. Adaptation of zebrafish to study seizures was initially established using the common convulsant agent pentylenetetrazole (PTZ). Larval PTZ-exposed zebrafish exhibit clear behavioral convulsions and abnormal electrographic activity, reminiscent of interictal and ictal epileptiform discharge. By using this model, our laboratory developed simple locomotion-based and electrophysiological assays to monitor and quantify seizures in larval zebrafish. Zebrafish also offer multiple advantages for rapid genetic manipulation and high-throughput phenotype-based drug screening. Combining these seizure assays with genetically modified zebrafish that represent Dravet syndrome, a rare genetic epilepsy, ultimately contributed to a phenotype-based screen of over 3500 drugs. Several drugs identified in these zebrafish screens are currently in clinical or compassionate-use trials. The emergence of this ‘aquarium-to-bedside’ approach suggests that broader efforts to adapt and improve upon this zebrafish-centric strategy can drive a variety of exciting new discoveries. Summary: Screening programs using zebrafish could reshape traditional approaches to antiepileptic drug discovery. Here we describe steps to develop zebrafish models that represent human epilepsies, with an emphasis on a zebrafish model of Dravet syndrome.
登录
查看更多内容
影响因子:
2.2
作者:
Baraban, SC;Wenzel, HJ;Schwartzkroin, PA
通讯作者:
Schwartzkroin, PA
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
3
作者:
Chege, Sally W.;Hortopan, Gabriela A.;Baraban, Scott C.
通讯作者:
Baraban, Scott C.
影响因子:
4.8
作者:
Auer, Thomas O.;Del Bene, Filippo
通讯作者:
Del Bene, Filippo
影响因子:
7.7
作者:
Dana, Hod;Mohar, Boaz;Kim, Douglas S.
通讯作者:
Kim, Douglas S.